For research use only. Not for therapeutic Use.
L-Kynurenine-d4-1 hydrochloride, a premium pharmaceutical research compound designed for advanced neurobiological and immunological studies. As a deuterated analog of L-Kynurenine, it offers enhanced stability and improved pharmacokinetic properties. L-Kynurenine-d4-1 hydrochloride is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for neurodegenerative diseases and immune system disorders. Trusted by leading laboratories, L-Kynurenine-d4-1 hydrochloride is your go-to solution for cutting-edge neurobiological and immunological research. Unlock new possibilities in neurological and immune system treatment with L-Kynurenine-d4-1 hydrochloride, where innovation meets reliability.
| Catalog Number | S000228 |
| Molecular Formula | C10H9D4ClN2O3 |
| Purity | ≥95% |
| IUPAC Name | (2S)-2-amino-4-(2-amino-3,4,5,6-tetradeuteriophenyl)-4-oxobutanoic acid;hydrochloride |
| InChI | InChI=1S/C10H12N2O3.ClH/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15;/h1-4,8H,5,11-12H2,(H,14,15);1H/t8-;/m0./s1/i1D,2D,3D,4D; |
| InChIKey | OFIBPTWHLILRDD-CKPDFBLXSA-N |
| SMILES | [2H]C1=C(C(=C(C(=C1[2H])C(=O)C[C@@H](C(=O)O)N)N)[2H])[2H].Cl |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-220. [2]. Nozaki K, et al. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J Cereb Blood Flow Metab. 1992 May;12(3):400-7. |
